TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients
NCT00289809
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma, Soft Tissue
Interventions
DRUG:
combination of TLC D-99 and Ifosfamide
Sponsor
Istituto Clinico Humanitas